Vincerx Pharma, Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-03-10: Reporting owner Rice Michael Yehuda; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-10: Reporting owner McDonald Andrew I; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-10: Reporting owner Dobkin David; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-03-10: Reporting owner GROSSMAN JONAS; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-03-10 | Rice Michael Yehuda Director, Officer (Chief Operating Officer), 10% Owner | 4 | Warrants Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,570,000 1,570,000 owned after | $0.50 | 2020-03-23 | |
| 2020-03-10 | McDonald Andrew I Director, Officer (Chief Executive Officer), 10% Owner | 4 | Warrants Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,570,000 1,570,000 owned after | $0.50 | 2020-03-12 | |
| 2020-03-10 | Dobkin David Director, Officer (Chief Financial Officer) | 4 | Warrants Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,570,000 1,570,000 owned after | $0.50 | 2020-03-12 | |
| 2020-03-10 | GROSSMAN JONAS Director, 10% Owner | 4 | Warrants Derivative · Indirect · See Footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000,000 1,000,000 owned after | $0.50 | 2020-03-12 |